Ex­clu­sive: With an eye to­ward ex­pan­sion, an AI com­pa­ny that sup­ports CD­MOs com­pletes $20M Se­ries C raise

An AI provider that caters to bio­phar­ma man­u­fac­tur­ers has closed a $20 mil­lion Se­ries C raise to ex­pand its op­er­a­tions and bring its third tech prod­uct to com­mer­cial­iza­tion. No­tably, the fund­ing round will in­crease its staff num­bers by more than 30% to over 100 em­ploy­ees.

Launched in 2014, San Fran­cis­co-based Aizon’s tech­nol­o­gy cap­tures da­ta from man­u­fac­tur­ing sites, which can then be used to im­prove drug pro­duc­tion. The com­pa­ny pro­vides its tech main­ly to CD­MOs and CMOs but has some phar­ma clients as well, CEO Pep Gubau told End­points News in an in­ter­view.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER